Home > Insider Trading > Filing (0001140361-16-060315)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1641489	Vtv Therapeutics Inc.	VTVT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1186472	O Ronald Perelman	C/O Macandrews &Amp; Forbes Incorporated 35 East 62Nd Street New York NY 10065		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2016-04-01	300,000	$5.20	2,290,666	No	4	P	Indirect	See footnote.
Class A Common Stock	Acquisiton	2016-04-05	100,000	$5.20	2,390,666	No	4	P	Indirect	See footnote.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote.
No	4	P	Indirect	See footnote.

Footnotes

Mr. Ronald O. Perelman is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). M&F Group and MFV hold the securities described above. Mr. Perelman, M&F Inc., M&F LLC, M&F Group, and MFV may be deemed to be directors by deputization of the Issuer by virtue of their relationship with Steven M. Cohen, Paul M. Meister and Paul G. Savas, directors of vTv Therapeutics Inc. (the "Issuer"), and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC.
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $5.09 to $5.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote to this Form 4.